Literature DB >> 22512959

Trends and attitudes in surgical management of benign prostatic hyperplasia.

Nora G Lee1, Hui Xue, Lori B Lerner.   

Abstract

INTRODUCTION: Surgical management of benign prostatic hyperplasia (BPH) has changed over the past 15 years with newer techniques emerging such as laser therapy that can be used with anticoagulation, an increasing issue with modern patients. We sought to evaluate current trends in procedure utilization based on age, location, type of practice, and experience. We also hoped to determine what factors influence surgeons' decisions to choose or reject particular surgical techniques. METHODS AND MATERIALS: A 90-item on-line survey was sent via electronic mail to the American Urological Association (AUA), Veterans Administration, Society for Government Service Urologists, and Endourological Society. Data concerning utilization of 12 BPH surgical techniques were analyzed and compared to the surgeons' demographics using categorical data analysis and logistic regression.
RESULTS: Of approximately 5500 urologists contacted, 600 urologists replied with 570 currently performing BPH surgery. The two procedures that continue to be utilized by urologists are open prostatectomy (OP) at 78% and monopolar transurethral resection of prostate (TURP) at 73%. When stratified by urologist age and year of residency completion, there were no differences in procedure utilization. There were no differences in types of procedures utilized between AUA sections except in the Northeastern AUA section which utilized less monopolar TURP and the New York section which utilized less photoselective vaporization (PVP). Higher volume surgeons were more likely to perform holmium laser enucleation of the prostate (HoLEP), diode laser vaporization of the prostate, holmium laser ablation of the prostate (HoLAP), and thulium laser ablation. There were no trends for low volume surgeons. There were no differences in types of procedures performed in full time academic versus non-academic settings except for robotic prostatectomy and button TURP which were utilized more often in academic settings. Urologists were more likely to accept a technique that produces good clinical outcomes, is safe in practice, and minimally invasive. Urologists reject procedures most frequently due to preference for another technique or lack of training/equipment. Interestingly, reimbursement/cost issues were never reported as primary reasons for acceptance/rejection of any approach.
CONCLUSIONS: Change in technology has led urologists to change their approach to surgical treatment of BPH. OP and monopolar TURP are still the procedures utilized by most urologists, however, laser therapy is emerging as a commonly used technique. As more high-risk patients are treated, laser therapies may become a more popularized technique. Further larger scale studies evaluating surgeon attitudes might clarify how changing technology influences practice patterns.

Entities:  

Mesh:

Year:  2012        PMID: 22512959

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  13 in total

Review 1.  In 2013, holmium laser enucleation of the prostate (HoLEP) may be the new 'gold standard'.

Authors:  Simon van Rij; Peter J Gilling
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

2.  Response to: Greenlight® users should move from photoselective vaporization to endoscopic enucleation in larger prostates : Benoit Peyronnet, Vincent Misrai, Tev Aho, Henry Woo, Thomas Herrmann, Fernando Gomez-Sancha.

Authors:  Malek Meskawi; Pierre Alain Hueber; Roger Valdivieso; Alexis E Te; Bilal Chugthai; Naeem Bhojani; Kevin C Zorn
Journal:  World J Urol       Date:  2017-10-17       Impact factor: 4.226

3.  Comparison of Vela and holmium laser enucleation of the prostate: a retrospective clinical trial with a 12-month follow-up.

Authors:  Meng Gu; Chong Liu; Yan-Bo Chen; Huan Xu; Shi Fu; Qi Chen; Zhong Wang
Journal:  Int Urol Nephrol       Date:  2018-03-24       Impact factor: 2.370

4.  The Informed Patient: An Analysis of Information Seeking Behavior and Surgical Outcomes Among Men With Benign Prostatic Hyperplasia.

Authors:  Haidar Abdul-Muhsin; Mark Tyson; Santanam Raghu; Mitchell Humphreys
Journal:  Am J Mens Health       Date:  2016-07-08

5.  Diode laser vaporisation of the prostate vs. diode laser under cold irrigation: A randomised control trial.

Authors:  Ravisankar G Pillai; Ziad Al Naieb; Stephen Angamuthu; Tintu Mundackal
Journal:  Arab J Urol       Date:  2014-11-20

6.  Day care monopolar transurethral resection of prostate: Is it feasible?

Authors:  Altaf Khan
Journal:  Urol Ann       Date:  2014-10

7.  Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules.

Authors:  Tyler M Bauman; Tristan M Nicholson; Lisa L Abler; Kevin W Eliceiri; Wei Huang; Chad M Vezina; William A Ricke
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

8.  Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study.

Authors:  M Hammad Mithani; Salman El Khalid; Shariq Anis Khan; Imran Sharif; Adnan Siddiq Awan; Shoaib Mithani; Irfan Majeed
Journal:  Investig Clin Urol       Date:  2018-10-18

9.  Postoperative infectious complications in our early experience with holmium laser enucleation of the prostate for benign prostatic hyperplasia.

Authors:  Katsumi Shigemura; Kazushi Tanaka; Takahiro Haraguchi; Fukashi Yamamichi; Mototsugu Muramaki; Hideaki Miyake; Masato Fujisawa
Journal:  Korean J Urol       Date:  2013-03-15

10.  Robot-assisted simple prostatectomy versus open simple prostatectomy: a single-center comparison.

Authors:  R Dotzauer; A La Torre; A Thomas; M P Brandt; K Böhm; R Mager; H Borgmann; W Jäger; M Kurosch; T Höfner; C Ruckes; A Haferkamp; I Tsaur
Journal:  World J Urol       Date:  2020-03-28       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.